OFIX Stock: Price, Forecast, Financials & AI Analysis

Loading chart...

High

13.290

Open

13.090

VWAP

13.00

Vol

246.00K

Mkt Cap

516.00M

Low

12.930

Amount

3.00M

EV/EBITDA(TTM)

15.00

Total Shares

40.00M

636.00M

EV/OCF(TTM)

22.00

P/S(TTM)

1.00

Orthofix Medical Inc. is a global medical technology company. The Company offers a portfolio of spinal hardware, bone growth therapies, specialized orthopedic solutions, biologics and enabling technologies, including the 7D FLASH navigation system. The Company’s Global Spine segment offers two primary product categories: bone growth therapies and spinal implants, biologics, and enabling technologies. The segment provides implantable medical devices, biologics, enabling technologies, and other regenerative solutions which aim to restore the quality of life of patients suffering from diseases and traumas of the spine. It offers a variety of treatment solutions that incorporate multiple treatment modalities, such as mechanical, biological, and electromagnetic modes. Its Global Orthopedics segment offers products and solutions for limb deformity correction and complex limb reconstruction with a focus on use in trauma, adult and pediatric limb reconstruction, and foot and ankle procedures.

Events Timeline

(ET)

2025-11-04

07:32:20

Orthofix Revises FY25 Revenue Forecast to $810M-$814M, Down from $808M-$816M

2025-11-04

07:30:24

Orthofix Announces Q3 Earnings Per Share of 57 Cents, Compared to 71 Cents Last Year

2025-08-05 (ET)

2025-08-05

07:46:06

Orthofix backs FY25 revenue view $808M-$816M, consensus $813.4M

2025-08-05

07:44:11

Orthofix reports Q2 EPS (36c) vs. (88c) last year

News

2.0

01-28NASDAQ.COM

Healthcare Stocks Surge in After-Hours Trading

2.0

01-16Globenewswire

Bone Grafts Market Report: Forecast to 2036

5.0

01-13Yahoo Finance

Orthofix CEO Massimo Calafiore Sells 19,397 Shares

9.5

2025-11-04NASDAQ.COM

Orthofix Medical Inc. Reports Reduced Losses in Q3

8.0

2025-10-29NASDAQ.COM

Significant Options Activity on Wednesday: DUOL, ORCL, OFIX

4.0

2025-10-23Benzinga

Barrington Research Reaffirms Outperform Rating for Orthofix Medical, Keeps $17 Price Target Intact

3 Analyst Rating

Wall Street analysts forecast OFIX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for OFIX is 21.33 USD with a low forecast of 18.00 USD and a high forecast of 24.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

3 Buy

0 Hold

0 Sell

Strong Buy

Current: 0.000

Low

18.00

Averages

21.33

High

24.00

Current: 0.000

Low

18.00

Averages

21.33

High

24.00

TD Cowen

Hold

initiated

$14

AI Analysis

2026-01-26

New

Reason

TD Cowen

Price Target

$14

AI Analysis

2026-01-26

New

initiated

Hold

Reason

TD Cowen initiated coverage of Orthofix with a Hold rating and $14 price target. The company is affecting enterprise-wide change while driving improving profitability and cash flow, even though its top-line acceleration is less visible today and may not be until late 2026, the analyst tells investors in a research note. TD adds that it is unequivocally positive on to-date/ongoing efforts to reshape the investment story, noting however that for the shares to "work", there needs to be evidence of accelerating sales.

Barrington

Michael Petusky

Outperform

maintain

$17 -> $18

2025-11-05

Reason

Barrington

Michael Petusky

Price Target

$17 -> $18

2025-11-05

maintain

Outperform

Reason

Barrington analyst Michael Petusky raised the firm's price target on Orthofix to $18 from $17 and keeps an Outperform rating on the shares. The company reported strong Q3 results and upped the low-end of its fiscal 2025 EBITDA outlook, the analyst tells investors in a research note.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for OFIX

Unlock Now

Valuation Metrics

The current forward P/E ratio for Orthofix Medical Inc (OFIX.O) is -8.78, compared to its 5-year average forward P/E of -13.75. For a more detailed relative valuation and DCF analysis to assess Orthofix Medical Inc 's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-13.75

Current PE

-8.78

Overvalued PE

88.39

Undervalued PE

-115.89

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

5Y Average EV/EBITDA

9.82

Current EV/EBITDA

7.76

Overvalued EV/EBITDA

12.67

Undervalued EV/EBITDA

6.96

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

0.96

Current PS

0.69

Overvalued PS

1.36

Undervalued PS

0.56

Financials

AI Analysis

Annual

Quarterly

Whales Holding OFIX

Paradigm Capital Management, Inc.

Rubric Capital Management LP

Armistice Capital LLC

Trading Trends

People Also Watch

Frequently Asked Questions

What is Orthofix Medical Inc (OFIX) stock price today?

The current price of OFIX is 13.23 USD — it has increased 0.76 % in the last trading day.

What is Orthofix Medical Inc (OFIX)'s business?

What is the price predicton of OFIX Stock?

Wall Street analysts forecast OFIX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for OFIX is21.33 USD with a low forecast of 18.00 USD and a high forecast of 24.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Orthofix Medical Inc (OFIX)'s revenue for the last quarter?

Orthofix Medical Inc revenue for the last quarter amounts to 206.00M USD, increased 4.59 % YoY.

What is Orthofix Medical Inc (OFIX)'s earnings per share (EPS) for the last quarter?

Orthofix Medical Inc. EPS for the last quarter amounts to -0.57 USD, decreased -19.72 % YoY.

How many employees does Orthofix Medical Inc (OFIX). have?

Orthofix Medical Inc (OFIX) has 1616 emplpoyees as of January 31 2026.

What is Orthofix Medical Inc (OFIX) market cap?

Today OFIX has the market capitalization of 516.00M USD.

OFIX Overview

OFIX Overview

Events Timeline

News

Valuation Metrics

Forward PE

Forward EV/EBITDA

Forward PS

Financials

Whales Holding OFIX

Trading Trends

People Also Watch

Frequently Asked Questions

What is Orthofix Medical Inc (OFIX) stock price today?

What is Orthofix Medical Inc (OFIX)'s business?

What is the price predicton of OFIX Stock?

What is Orthofix Medical Inc (OFIX)'s revenue for the last quarter?

What is Orthofix Medical Inc (OFIX)'s earnings per share (EPS) for the last quarter?

How many employees does Orthofix Medical Inc (OFIX). have?

What is Orthofix Medical Inc (OFIX) market cap?